India's COVID-19 tally had crossed the 20-lakh mark on August 7, 30 lakh on August 23 and 40 lakh on September 5. It went past 50 lakh on September 16, 60 lakh on September 28 and crossed 70 lakh on October 11.
There is no scientific evidence so far to support the need for a booster vaccine dose against COVID-19, ICMR Director General Dr Balram Bhargava said on Monday underlining the completion of second dose for India's adult population is the priority for the government for now.
The most important finding of the study was that the Spike-protein neutralising antibodies found in the mixed vaccine groups were significantly higher than the same-vaccine groups, D Nageshwar Reddy, Chairman of AIG Hospitals said.
COVID-19 is on the verge of becoming endemic but Indian scientists are keeping a close watch on each new variant and the government would continue to maintain a high alert, Union health minister Mansukh Mandaviya has said, underlining that the virus has managed to survive and is going to stay.
The country's active caseload increased to 2,10,544 and constitutes 1.85 per cent of the total infections. The recovery rate dropped to 96.75 per cent from 96.82 per cent on Saturday.
Indian loses chance to be research hub as domestic drug companies move R&D overseas.
India saw 81,466 new coronavirus infections being reported in a span of 24 hours, the highest single-day rise in six months, taking the COVID-19 tally of cases to 1,23,03,131, according to the Union health ministry data updated on Friday.
The death toll has climbed to 5,26,600 with 70 new fatalities, the data updated at 8 am stated.
The National Science Foundationis an independent agency of the United States government that supports fundamental research and education in all the non-medical fields of science and engineering. Its medical counterpart is the National Institutes of Health.
The number of people who have recuperated from the disease surged to 4,25,94,801. The case fatality rate stood at 1.22 per cent, it said.
A total of 25,12,388 samples have been tested for coronavirus infection as on 9 am, May 20 all over the country.
According to the Indian Council of Medical Research, 22,82,80,763 samples have been tested up to March 15, with 8,73,350 samples tested on Monday
India has crossed the 3-crore mark in Covid-19 tests and its tests per million stand at 21,769. Where does that place India vis--vis other nations?
In a series of tweets after the Drugs Controller General of India (DCGI) approved Oxford's vaccine Covishield and Bharat Biotech's Covaxin for restricted emergency use, Modi said it will make every Indian proud that both the vaccines are made in India.
The Indian Council of Medical Research's national task force for COVID-19 has decided against including antiviral drug Molnupiravir in the clinical management protocol for COVID-19 as of now, official sources said on Tuesday.
The death toll has climbed to 5,24,157 with 54 fatalities, the data updated at 8 am stated.
There are 8,82,542 active cases of the infection in the country which comprises 20.99 per cent of the total caseload, the data stated.
The Commission has desired to incorporate Aadhaar-based fingerprint authentication (else digital fingerprint capturing) and facial recognition of candidates, scanning of QR Code of e-admit cards and monitoring through live AI-based CCTV video surveillance, it said.
In the case of double-income couples, not more than 40 per cent of the net income of one partner should be the EMI for the property.
The active cases constitute 0.05 per cent of the total infections.
There are 6,76,514 active cases of coronavirus infection in the country which is 24.45 per cent of the total caseload, while the number of recoveries has surged to 20,37,870.
The country's COVID-19 count includes 6,73,166 active cases, 19,77,780 discharged/migrated patients.
The COVID-19 case fatality rate was recorded at 1.49 per cent.
The daily positivity rate was recorded at 0.98 per cent while the weekly figure was recorded at 0.76 per cent, the ministry said.
The number of people who have recuperated from the disease surged to 86,04,955 pushing the national recovery rate to 93.76 per cent
The death toll due to coronavirus infection climbed to 49,980 with 944 people succumbing to the disease in a span of 24 hours, the data updated at 8 am showed.
The number of active COVID-19 cases stands at 2,15,125, while 3,34,821 patients have been cured/discharged.
The total coronavirus cases in the country have mounted to 23,29,638, while the death toll climbed to 46,091 with 834 new fatalities being reported in a span of 24 hours, the data updated at 8 am showed.
During the same period, 117 fatalities were recorded, also the lowest in over eight months, taking the death toll to 1,53,587.
The Centre on Saturday night announced that the probe into alleged irregularities in the medical entrance exam NEET will be handed over to the CBI for a comprehensive investigation.
The fatality rate has further dropped to 2.07 per cent, the data stated.
The active cases comprise 0.26 per cent of the total infections, while the national COVID-19 recovery rate was recorded at 98.53 per cent, the ministry said.
The decline in the effectiveness of Covaxin, India's indigenous COVID-19 vaccine, from 77.8 per cent to 50 per cent during a Delta-driven case surge in April and May this year is neither bad nor surprising, say scientists.
With the fresh cases, India's COVID-19 tally rose to 22.68 lakh, while the recoveries have surged to 15,83,489, pushing the recovery rate to 69.80 per cent.
So far, less than 1 per cent of the target population of 77 crore in the 18-59 age group have been administered the precaution dose.
The death toll climbed to 5,25,242 with 19 new fatalities, the data updated at 8 am stated.
Niclosamide, a drug on the World Health Organisation's list of essential medicines, has been used to treat tapeworm infestation for more than 50 years. The oral antiviral drug was also used to treat patients during the SARS outbreak of 2003-04.
The health ministry said that 5,22,149 deaths have been reported so far in the country.
The COVID-19 active caseload remained below 3 lakh on Saturday.
After having received the government purchase order for 55 lakh doses, Bharat Biotech shipped the first batch of vaccines (each vial containing 20 doses) to Gannavaram (Vijayawada), Guwahati, Patna, Delhi, Kurukshetra, Bangalore, Pune, Bhubaneswar, Jaipur, Chennai and Lucknow.
